Xenon Pharmaceuticals (NASDAQ:XENE) Stock: Insider Ian Mortimer Buys 30,000 Shares
MarketBeat
Xenon Pharmaceuticals Inc. (NASDAQ:XENE - Get Free Report) CEO Ian Mortimer acquired 30,000 shares of the stock in a transaction dated Wednesday, September 30th. The stock was bought at an average cost of $37.38 per share, with a total value of $1,121,400.00. Following the completion of the purchase, the chief executive officer directly owned 49,923 shares in the company, valued at approximately $1,866,121.74. The trade was a 150.58% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link.
NASDAQ:XENE